149 related articles for article (PubMed ID: 7777100)
1. C1Q complexes with beta-2-microglobulin and amyloid P-component in sera of patients with dialysis-associated amyloidosis.
Hasegawa M; Kawashima S; Shikano M; Kojima K; Yanai T; Hassegawa H; Tomita M; Murakami K; Kawamura N; Katsumata H
Nephron; 1995; 69(4):380-3. PubMed ID: 7777100
[TBL] [Abstract][Full Text] [Related]
2. Formation of amyloid-like substance from beta-2-microglobulin in vitro. Role of serum amyloid P component: a preliminary study.
Ono K; Uchino F
Nephron; 1994; 66(4):404-7. PubMed ID: 8015642
[TBL] [Abstract][Full Text] [Related]
3. Serum amyloid P component: a predictor of clinical beta 2-microglobulin amyloidosis.
Spiegel DM; Sprague SM
Am J Kidney Dis; 1992 May; 19(5):427-32. PubMed ID: 1585929
[TBL] [Abstract][Full Text] [Related]
4. Beta 2-microglobulin serum concentration and associated amyloidosis in dialysis patients.
Stein G; Schneider A; Thoss K; Ritz E; Schaefer K; Hüller M; Sperschneider H; Marzoll I
Nephrol Dial Transplant; 1991; 6 Suppl 3():57-61. PubMed ID: 1775270
[TBL] [Abstract][Full Text] [Related]
5. [Scintigraphy of iodine 123 labelled serum amyloid P component in beta 2-microglobulin amyloidosis of hemodialysis].
Flipo RM; Deveaux M; Duneton O; Foissac-Gegoux P; Dumont A; Duquesnoy B; Marchandise X
Nephrologie; 1995; 16(6):419-25. PubMed ID: 8524449
[TBL] [Abstract][Full Text] [Related]
6. Serum beta 2-microglobulin concentration in dialysis patients: importance of intrinsic renal function.
McCarthy JT; Williams AW; Johnson WJ
J Lab Clin Med; 1994 Apr; 123(4):495-505. PubMed ID: 8144998
[TBL] [Abstract][Full Text] [Related]
7. Polymerization of intact beta 2-microglobulin in tissue causes amyloidosis in patients on chronic hemodialysis.
Gorevic PD; Munoz PC; Casey TT; DiRaimondo CR; Stone WJ; Prelli FC; Rodrigues MM; Poulik MD; Frangione B
Proc Natl Acad Sci U S A; 1986 Oct; 83(20):7908-12. PubMed ID: 3532124
[TBL] [Abstract][Full Text] [Related]
8. Plasma kinetics of 125I-labelled amyloid P component in beta 2M amyloidosis: a possible approach to quantitate disease activity.
Zingraff J; Caillat-Vigneron N; Ureña P; Gagné ER; Bererhi L; Moretti JL; Bardin T; Drüeke TB
Nephrol Dial Transplant; 1995; 10(2):223-9. PubMed ID: 7753457
[TBL] [Abstract][Full Text] [Related]
9. Does dialysis-associated amyloidosis resolve after transplantation?
Nelson SR; Sharpstone P; Kingswood JC
Nephrol Dial Transplant; 1993; 8(4):369-70. PubMed ID: 7685506
[No Abstract] [Full Text] [Related]
10. Beta 2-microglobulin amyloidosis in hemodialysis patients. An autopsy study of intervertebral disks and posterior longitudinal ligaments.
Honda K; Hara M; Ogura Y; Nihei H; Mimura N
Acta Pathol Jpn; 1990 Nov; 40(11):820-6. PubMed ID: 2127652
[TBL] [Abstract][Full Text] [Related]
11. Detection of novel beta 2-microglobulin in the serum of hemodialysis patients and its amyloidogenic predisposition.
Ogawa H; Saito A; Oda O; Nakajima M; Chung TG
Clin Nephrol; 1988 Sep; 30(3):158-63. PubMed ID: 3052955
[TBL] [Abstract][Full Text] [Related]
12. [Beta 2-microglobulin--its role in renal failure and hemodialysis therapy].
Czyz W; Szepietowski T
Postepy Hig Med Dosw; 1992; 46(2):209-38. PubMed ID: 1470582
[TBL] [Abstract][Full Text] [Related]
13. Modification of beta 2m with advanced glycation end products as observed in dialysis-related amyloidosis by 3-DG accumulating in uremic serum.
Niwa T; Katsuzaki T; Momoi T; Miyazaki T; Ogawa H; Saito A; Miyazaki S; Maeda K; Tatemichi N; Takei Y
Kidney Int; 1996 Mar; 49(3):861-7. PubMed ID: 8648931
[TBL] [Abstract][Full Text] [Related]
14. Long-term complications of dialysis: pathogenic factors with special reference to amyloidosis.
Gejyo F; Homma N; Arakawa M
Kidney Int Suppl; 1993 Jun; 41():S78-82. PubMed ID: 8320951
[TBL] [Abstract][Full Text] [Related]
15. Involvement of beta 2-microglobulin modified with advanced glycation end products in the pathogenesis of hemodialysis-associated amyloidosis. Induction of human monocyte chemotaxis and macrophage secretion of tumor necrosis factor-alpha and interleukin-1.
Miyata T; Inagi R; Iida Y; Sato M; Yamada N; Oda O; Maeda K; Seo H
J Clin Invest; 1994 Feb; 93(2):521-8. PubMed ID: 8113390
[TBL] [Abstract][Full Text] [Related]
16. Haemodialysis-associated beta 2M amyloidosis: current controversies.
Stein G; Sperschneider H; Fünfstück R; Ritz E
Nephrol Dial Transplant; 1994; 9 Suppl 3():48-50. PubMed ID: 8072726
[TBL] [Abstract][Full Text] [Related]
17. [Significance of serum levels of beta-2-microglobulin in dialysis patients].
Baldrati L; Baldrati L; Delvecchio C; Capponcini C; Docci D; Turci F; Feletti C
Recenti Prog Med; 1990 Sep; 81(9):561-3. PubMed ID: 2263750
[TBL] [Abstract][Full Text] [Related]
18. Tumoral amyloidosis of bone of beta 2-microglobulin origin in association with long-term hemodialysis: a new type of amyloid disease.
Casey TT; Stone WJ; DiRaimondo CR; Brantley BD; DiRaimondo CV; Gorevic PD; Page DL
Hum Pathol; 1986 Jul; 17(7):731-8. PubMed ID: 3087858
[TBL] [Abstract][Full Text] [Related]
19. [Amyloidosis associated with chronic hemodialysis. The prognostic significance of beta 2-microglobulin changes in patients with terminal chronic kidney failure treated by repeated hemodialysis].
Manasia M; Meseşan M; Gherman-Căprioară M; Malide D; Paţiu IM; Pârvu L; Vlăduţiu D; Spânu CS
Med Interna; 1991; 43(1-2):129-34. PubMed ID: 1670118
[TBL] [Abstract][Full Text] [Related]
20. Serum alpha 2-macroglobulin in haemodialysis patients: baseline and kinetic studies.
Argilés A; Kerr PG; Mourad G; Mion CM; Atkins RC
Nephrol Dial Transplant; 1993; 8(10):1118-23. PubMed ID: 7505905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
